woes continue with negative actions by
Morgan Stanley Dean Witter
. Morgan Stanley cut it to outperform from neutral and Goldman slashed its 2000 EPS estimate to $1.60 from $1.83 a share and 2001 EPS estimate to $1.45 from $1.90 a share.
earnings estimates were cut by
after the company said October's same-store sales fell 2%. The firm cut the 2000 EPS estimate to $1 from $1.11 and its 2001 EPS estimate to $1.35 from $1.50.
: UP to buy from hold at
Credit Suisse First Boston.
: UP to buy from outperform at
Salomon Smith Barney
: UPPED intermediate-term rating to buy from accumulate at
; 2000 EPS UP to 64 cents from 60 cents and 2001 EPS estimate UP to $1.50 from $1.40.
Foundation Health Systems
: UP to attractive from neutral at
; price target: $23.50.
: UP to buy from market perform at
Deutsche Banc Alex. Brown
: UP to buy from hold at CSFB; 12-month price target: $41 to $42.
: DOWN to market performer from buy at
: DOWN to market perform from market outperform at Goldman Sachs; and DOWN to long-term attractive from buy at
: DOWN to market perform from strong buy at Alex. Brown.
: DOWN to neutral from attractive at
; 2001 EPS estimate DOWN to $3.90 from $4.20.
: DOWN to buy from strong buy at